Case File
efta-02382763DOJ Data Set 11OtherEFTA02382763
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02382763
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Vinit Sahni
Sent:
Friday, May 2, 2014 1:02 PM
To:
jeffrey E.
Subject:
Re: Jeffrey - Payrolls [C]
Classification: Confidential
Sure lets chat mond=y, what time works and what number.
=b> From: "jeffrey E." [[email protected]] &n=sp; Sent: 05/02/2014 02:57 PM ZE2
To: Vinit Sahni
=b> Subject: Re: Jeffrey - Payrolls [C]
monday
On Fri, May 2, 2014 at 2:53 PM, Vinit Sahni
wrote:
Classification: Co=fidential
Jeffrey - strong payrolls, positioning was short into the number, reaction could have been more violent.
Confirms view that US growth is strong and this could be the start of the market buying the fact that we will see a strong
US recovery. Brings us back to US equity growth baskets, US rates higher especially 5s and possibly SySy, Equity over
credit as volatility picks up...we are now going back to the drawing board and will look for ideas this weekend.
if u have 2 mins Nav and I can get on the phone with u
Best
Vinit
Vinit Sahni
Managing Director ] Global Head - Professional Client Group & Key Client Partners Capital Markets Group
Deutsche Asset & Wealth Management
105/108 Old Broad St (Pinners Hall),
EC2N lEN London, United Kingdom
Tel.
EFTA_R1_01398870
EFTA02382763
Mobile
Email
Any proposed ideas are being delivered to you by the DeAWM Key Client Partn=rs ("KCP") London desk for
discussion purposes only, and do not create any legally binding obligation on the part of Deutsche Bank AG and / or its
affiliates ("DB"). These ideas are for the consideration of the intended recipients of this mail only. The KCP London desk
does not provide investment advice. All intended recipients are Professional investors (as defined by MiFID), who
understand the strategy, characteristi=s and risks associated with any ideas proposed herein and will be able to evaluate
it independently. All trades on proposed ideas shall be subject to the relevant internal approvals prior to execution.
This e-mail may contain confidential and/or privileged information. If you =re not the intended recipient (or
have received this e-mail in error) plea=e notify the sender immediately and delete this e-mail. Any unauthorized
c=pying, disclosure or distribution of the material in this e-mail is strict=y forbidden.
Please refer to http://www.db.com/en/content/eu_disclosures.htm for =dditional EU corporate and regulatory
disclosures and to http://www=db.com/unitedkingdom/content/privacy.htm
<httpl=www.db.com/unitedkingdom/content/privacy.htm> for information about privacy=
=C2
please note
The information contained in t=is communication is confidential, may be attorney-client privileged, ma= constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unau=horized
use, disclosure or copying of this communication or any part th=reof is strictly prohibited and may be unlawful. If you
have received t=is communication in error, please notify us immediately by return e-mail or=by e-mail to
[email protected] <mailto:[email protected]> , and destroy this communication and all copies t=ereof,
including all attachments. copyright -all rights reserved
This e-mail may contain confidential and/or privileged information. If you =re not the intended recipient (or have
received this e-mail in error) plea=e notify the sender immediately and delete this e-mail. Any unauthorized c=pying,
disclosure or distribution of the material in this e-mail is strict=y forbidden.
Please refer to http://www.db.com/en/content/eu_disclosures.htm for additio=al EU corporate and regulatory
disclosures and to http://www.db.com/united=ingdom/content/privacy.htm for information about privacy.
2
EFTA_R1_01398871
EFTA02382764
Technical Artifacts (7)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Phone
2382763Phone
2382764URL
http://www.db.com/en/content/eu_disclosures.htmURL
http://www.db.com/united=ingdom/content/privacy.htmURL
http://www=db.com/unitedkingdom/content/privacy.htmRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.